• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Proc Natl Acad Sci U S A . Oligomerization-driven avidity correlates with SARS-CoV-2 cellular binding and inhibition

tetano

Editor, Senior Moderator
Proc Natl Acad Sci U S A


. 2024 Oct;121(40):e2403260121.
doi: 10.1073/pnas.2403260121. Epub 2024 Sep 19. Oligomerization-driven avidity correlates with SARS-CoV-2 cellular binding and inhibition

Roi Asor[SUP] 1 2 [/SUP], Anna Olerinyova[SUP] 1 2 [/SUP], Sean A Burnap[SUP] 2 3 [/SUP], Manish S Kushwah[SUP] 1 2 [/SUP], Fabian Soltermann[SUP] 1 2 [/SUP], Lucas S P Rudden[SUP] 4 [/SUP], Mario Hensen[SUP] 2 3 [/SUP], Snežana Vasiljevic[SUP] 2 3 [/SUP], Juliane Brun[SUP] 2 3 [/SUP], Michelle Hill[SUP] 2 3 [/SUP], Liu Chang[SUP] 5 6 [/SUP], Wanwisa Dejnirattisai[SUP] 5 7 [/SUP], Piyada Supasa[SUP] 5 [/SUP], Juthathip Mongkolsapaya[SUP] 5 6 [/SUP], Daming Zhou[SUP] 8 [/SUP], David I Stuart[SUP] 8 9 [/SUP], Gavin R Screaton[SUP] 5 10 [/SUP], Matteo T Degiacomi[SUP] 4 [/SUP], Nicole Zitzmann[SUP] 2 3 [/SUP], Justin L P Benesch[SUP] 1 2 [/SUP], Weston B Struwe[SUP] 2 3 [/SUP], Philipp Kukura[SUP] 1 2 [/SUP]



Affiliations
Free article Abstract

Cellular processes are controlled by the thermodynamics of the underlying biomolecular interactions. Frequently, structural investigations use one monomeric binding partner, while ensemble measurements of binding affinities generally yield one affinity representative of a 1:1 interaction, despite the majority of the proteome consisting of oligomeric proteins. For example, viral entry and inhibition in SARS-CoV-2 involve a trimeric spike surface protein, a dimeric angiotensin-converting enzyme 2 (ACE2) cell-surface receptor and dimeric antibodies. Here, we reveal that cooperativity correlates with infectivity and inhibition as opposed to 1:1 binding strength. We show that ACE2 oligomerizes spike more strongly for more infectious variants, while exhibiting weaker 1:1 affinity. Furthermore, we find that antibodies use induced oligomerization both as a primary inhibition mechanism and to enhance the effects of receptor-site blocking. Our results suggest that naive affinity measurements are poor predictors of potency, and introduce an antibody-based inhibition mechanism for oligomeric targets. More generally, they point toward a much broader role of induced oligomerization in controlling biomolecular interactions.

Keywords: SARS-CoV-2; avidity-based neutralization potency; label-free single-molecule tracking; mass photometry; receptor oligomerization.

 
Back
Top Bottom